UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$1.48B |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$690M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$588M |
| 4 |
Truist Financial
TFC
|
+$532M |
| 5 |
VanEck Gold Miners ETF
GDX
|
+$278M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.3B |
| 2 |
Alibaba
BABA
|
+$771M |
| 3 |
AABA
Altaba Inc
AABA
|
+$759M |
| 4 |
STI
SunTrust Banks, Inc.
STI
|
+$503M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$467M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.82% |
| 2 | Financials | 7.38% |
| 3 | Healthcare | 6.65% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Industrials | 5.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3401
Renasant Corp
RNST
$3.91B
| $2.32M | ﹤0.01% |
65,584
+6,332
| +11% | +$223K |
|
|
GOOD
3402
Gladstone Commercial Corp
GOOD
$627M
| $2.32M | ﹤0.01% |
106,224
+8,792
| +9% | +$200K |
|
3403
Dynatrace
DT
$14.2B
| $2.32M | ﹤0.01% |
91,700
-11,882
| -11% | -$261K |
|
|
JPXN
3404
iShares JPX-Nikkei 400 ETF
JPXN
$140M
| $2.32M | ﹤0.01% |
36,333
-6,295
| -15% | -$399K |
|
|
MRTX
3405
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $2.32M | ﹤0.01% |
17,980
-64,876
| -78% | -$6.26M |
|
3406
Heron Therapeutics
HRTX
$92.9M
| $2.31M | ﹤0.01% |
98,536
-142,312
| -59% | -$3.15M |
|
3407
CALL
Danaher
DHR
$144B
| $2.3M | ﹤0.01% |
16,920
-16,920
| -50% | -$2.14M |
|
3408
Levi Strauss
LEVI
$9.39B
| $2.3M | ﹤0.01% |
119,269
+63,833
| +115% | +$1.14M |
|
3409
Harley-Davidson
HOG
$2.71B
| $2.29M | ﹤0.01% |
61,717
-5,436
| -8% | -$202K |
|
3410
Zscaler
ZS
$27.3B
| $2.29M | ﹤0.01% |
49,368
-28,146
| -36% | -$1.31M |
|
3411
BlackRock MuniHoldings California Quality Fund
MUC
$1.01B
| $2.29M | ﹤0.01% |
163,911
+14,121
| +9% | +$198K |
|
3412
Lattice Semiconductor
LSCC
$18.5B
| $2.29M | ﹤0.01% |
119,470
+12,562
| +12% | +$241K |
|
3413
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$784M
| $2.29M | ﹤0.01% |
103,190
-460
| -0.4% | -$9.6K |
|
3414
Park National Corp
PRK
$3.67B
| $2.28M | ﹤0.01% |
22,308
+1,688
| +8% | +$169K |
|
|
CLDT
3415
Chatham Lodging
CLDT
$586M
| $2.28M | ﹤0.01% |
124,391
+22,503
| +22% | +$406K |
|
3416
CALL
Peabody Energy
BTU
$2.9B
| $2.28M | ﹤0.01% |
+250,000
| New | +$2.87M |
|
3417
SolarEdge
SEDG
$1.95B
| $2.28M | ﹤0.01% |
23,972
-16,387
| -41% | -$1.4M |
|
3418
John Hancock Multifactor Small Cap ETF
JHSC
$741M
| $2.28M | ﹤0.01% |
81,825
-37
| -0% | -$998 |
|
3419
Dr. Reddy's Laboratories
RDY
$10.2B
| $2.27M | ﹤0.01% |
279,840
-3,250
| -1% | -$25.7K |
|
3420
CALL
FedEx
FDX
$75.4B
| $2.27M | ﹤0.01% |
+15,000
| New | +$2.31M |
|
|
ERF
3421
DELISTED
Enerplus Corporation
ERF
| $2.27M | ﹤0.01% |
317,745
+39,240
| +14% | +$256K |
|
3422
PUT
Corning
GLW
$143B
| $2.27M | ﹤0.01% |
77,800
| – | – |
|
3423
KraneShares Bosera MSCI China A 50 Connect Index ETF
KBA
$150M
| $2.26M | ﹤0.01% |
69,379
-5,500
| -7% | -$172K |
|
|
GDO
3424
Western Asset Global Corporate Defined Opportunity Fund
GDO
$77.4M
| $2.26M | ﹤0.01% |
123,907
+39,516
| +47% | +$693K |
|
|
ATRI
3425
DELISTED
Atrion Corp
ATRI
| $2.26M | ﹤0.01% |
3,003
+640
| +27% | +$483K |
|
Similar funds
UBS Group's Q4 2019 Portfolio in Review
As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q4 2019 filing shows 808 new, 4,306 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.
By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
- UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
- UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
- UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
- UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
- UBS Group opened 808 new positions and closed 688 in Q4 2019.
- UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.
Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.